Group One Trading’s Akcea Therapeutics Inc AKCA Stock Holding History

Group One Trading’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,800	Closed	-$232K	–	7334
2020 Q3	$232K	Buy	12,800 +11,252	+727%	+$160K	﹤0.01%	3536
2020 Q2	$21K	Sell	1,548 -2,258	-59%	-$34.8K	﹤0.01%	4818
2020 Q1	$54K	Buy	3,806 +729	+24%	+$12K	﹤0.01%	3670
2019 Q4	$52K	Buy	3,077 +444	+17%	+$8.26K	﹤0.01%	3989
2019 Q3	$41K	Sell	2,633 -7,350	-74%	-$157K	﹤0.01%	4069
2019 Q2	$234K	Buy	+9,983	New	+$247K	﹤0.01%	2735

Group One Trading's AKCA Position: Q4 2020 in Review

Group One Trading sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 12,800 shares — an estimated $232K sold.

Group One Trading first reported a position in AKCA in Q2 2019 and held it in 6 quarters. The position peaked at $234K in Q2 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Group One Trading reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Group One Trading sold 12,800 Akcea Therapeutics Inc shares in Q4 2020, an estimated $232K.
Group One Trading first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 6 quarters.
Group One Trading's Akcea Therapeutics Inc position peaked at $234K in Q2 2019.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.